Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Choosing the harder road: Naming the challenges for families in person-centred planning.

Ellem K, Chenoweth L, Edwards R.

J Intellect Disabil. 2019 Sep;23(3):397-412. doi: 10.1177/1744629518784154. Epub 2018 Jul 18.

PMID:
30021501
2.

Crafting and retelling everyday lives--disabled people's contribution to bioethical concerns.

Matthews N, Ellem K, Chenoweth L.

Narrat Inq Bioeth. 2013 Winter;3(3):235-40. doi: 10.1353/nib.2013.0074.

PMID:
24407131
3.

Increased activity of cell surface peptidases in HeLa cells undergoing UV-induced apoptosis is not mediated by caspase 3.

Piva TJ, Davern CM, Hall PM, Winterford CM, Ellem KA.

Int J Mol Sci. 2012;13(3):2650-75. doi: 10.3390/ijms13032650. Epub 2012 Feb 28.

4.

Dendritic cell immunotherapy for stage IV melanoma.

O'Rourke MG, Johnson MK, Lanagan CM, See JL, O'Connor LE, Slater GJ, Thomas D, Lopez JA, Martinez NR, Ellem KA, Schmidt CW.

Melanoma Res. 2007 Oct;17(5):316-22.

PMID:
17885587
5.

Facultative or obligate anaerobic bacteria have the potential for multimodality therapy of solid tumours.

Wei MQ, Ellem KA, Dunn P, West MJ, Bai CX, Vogelstein B.

Eur J Cancer. 2007 Feb;43(3):490-6. Epub 2006 Nov 17. Review.

PMID:
17113280
6.
7.

An extraordinarily high level of IL-15 expression by a cell line transduced with a modified BMGneo vector displays hypoxic upregulation.

Huang XQ, Hamilton MJ, Li CL, Schmidt C, Ellem KA.

Mol Biotechnol. 2006 May;33(1):49-56.

PMID:
16691006
8.

Immunological characteristics correlating with clinical response to immunotherapy in patients with advanced metastatic melanoma.

Marshall JA, Forster TH, Purdie DM, Lanagan CM, O'Connor LE, O'Rourke MG, Johnson MK, See JL, Ellem KA, Martinez NR, López JA, Schmidt CW.

Immunol Cell Biol. 2006 Jun;84(3):295-302.

PMID:
16681827
9.

The Development and Characterization of an HEK293-Derived Cell Line for Use in an Intratumoral Cytokine Delivery System.

Hamilton MJ, Huang QX, Li CL, Ellem KAO.

Cell Transplant. 2006 Apr;15(4):343-350. doi: 10.3727/000000006783981891.

PMID:
28863748
10.

Search for "weapons of mass destruction" for cancer -- immuno/ gene therapy comes of age.

Wei MQ, Metharom P, Ellem KA, Barth S.

Cell Mol Immunol. 2005 Oct;2(5):351-7. Review.

11.

Gene transfer to dendritic cells induced a protective immunity against melanoma.

Metharom P, Ellem KA, Wei MQ.

Cell Mol Immunol. 2005 Aug;2(4):281-8.

12.
13.

Microarray expression profiling in melanoma reveals a BRAF mutation signature.

Pavey S, Johansson P, Packer L, Taylor J, Stark M, Pollock PM, Walker GJ, Boyle GM, Harper U, Cozzi SJ, Hansen K, Yudt L, Schmidt C, Hersey P, Ellem KA, O'Rourke MG, Parsons PG, Meltzer P, Ringnér M, Hayward NK.

Oncogene. 2004 May 20;23(23):4060-7.

PMID:
15048078
14.

Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine.

O'Rourke MG, Johnson M, Lanagan C, See J, Yang J, Bell JR, Slater GJ, Kerr BM, Crowe B, Purdie DM, Elliott SL, Ellem KA, Schmidt CW.

Cancer Immunol Immunother. 2003 Jun;52(6):387-95. Epub 2003 Apr 8.

PMID:
12682787
15.

Treatment of non-resectable hepatocellular carcinoma with autologous tumor-pulsed dendritic cells.

Ladhams A, Schmidt C, Sing G, Butterworth L, Fielding G, Tesar P, Strong R, Leggett B, Powell L, Maddern G, Ellem K, Cooksley G.

J Gastroenterol Hepatol. 2002 Aug;17(8):889-96.

PMID:
12164965
16.

Lentiviral vector-mediated tyrosinase-related protein 2 gene transfer to dendritic cells for the therapy of melanoma.

Metharom P, Ellem KA, Schmidt C, Wei MQ.

Hum Gene Ther. 2001 Dec 10;12(18):2203-13.

PMID:
11779404
17.

John Kerr and apoptosis.

O'Rourke MG, Ellem KA.

Med J Aust. 2000 Dec 4-18;173(11-12):616-7.

PMID:
11379508
18.
19.

Development of disabled, replication-defective gene transfer vectors from the Jembrana disease virus, a new infectious agent of cattle.

Metharom P, Takyar S, Xia HQ, Ellem KA, Wilcox GE, Wei MQ.

Vet Microbiol. 2001 May 3;80(1):9-22.

PMID:
11278119
20.

Increased cell surface protease activity in UV-irradiated cells undergoing apoptosis.

Piva TJ, Davern CM, Winterford CM, Ellem KA.

Redox Rep. 2000;5(2-3):133-6.

PMID:
10939294
21.

Novel bovine lentiviral vectors based on Jembrana disease virus.

Metharom P, Takyar S, Xia HH, Ellem KA, Macmillan J, Shepherd RW, Wilcox GE, Wei MQ.

J Gene Med. 2000 May-Jun;2(3):176-85.

PMID:
10894263
22.

Centrosomal and cytoplasmic Cdc2/cyclin B1 activation precedes nuclear mitotic events.

De Souza CP, Ellem KA, Gabrielli BG.

Exp Cell Res. 2000 May 25;257(1):11-21.

PMID:
10854050
23.

Increased ecto-metallopeptidase activity in cells undergoing apoptosis.

Piva TJ, Davern CM, Francis KG, Chojnowski GM, Hall PM, Ellem KA.

J Cell Biochem. 2000 Jan;76(4):625-38.

PMID:
10653982
24.

Multiple splicing variants of cdc25B regulate G2/M progression.

Forrest AR, McCormack AK, DeSouza CP, Sinnamon JM, Tonks ID, Hayward NK, Ellem KA, Gabrielli BG.

Biochem Biophys Res Commun. 1999 Jul 5;260(2):510-5.

PMID:
10403798
25.

Tumor metastasis biopsy as a surrogate marker of response to melanoma immunotherapy.

Zehntner S, Townsend W, Parkes J, Schmidt C, Down M, Bell J, Mulligan R, O'Rourke M, Ellem K, Thomas R.

Pathology. 1999 May;31(2):116-22. Erratum in: Pathology 2000 Feb;32(1):following 64.

PMID:
10399166
26.

A cyclin D-Cdk4 activity required for G2 phase cell cycle progression is inhibited in ultraviolet radiation-induced G2 phase delay.

Gabrielli BG, Sarcevic B, Sinnamon J, Walker G, Castellano M, Wang XQ, Ellem KA.

J Biol Chem. 1999 May 14;274(20):13961-9.

27.

Effect of UV irradiation on cell surface protease activity and amino acid uptake.

Piva TJ, Francis KG, Krause DR, Chojnowski GM, Ellem KA.

Mutat Res. 1998 Nov 9;422(1):55-67.

PMID:
9920428
28.

Involvement of p16CDKN2A in cell cycle delays after low dose UV irradiation.

Milligan A, Gabrielli BG, Clark JM, Hayward NK, Ellem KA.

Mutat Res. 1998 Nov 9;422(1):43-53.

PMID:
9920427
29.

The labyrinthine ways of cancer immunotherapy--T cell, tumor cell encounter: "how do I lose thee? Let me count the ways".

Ellem KA, Schmidt CW, Li CL, Misko I, Kelso A, Sing G, Macdonald G, O'Rourke MG.

Adv Cancer Res. 1998;75:203-49. Review. No abstract available.

PMID:
9709811
30.

Immunotherapy, including gene therapy, for metastatic melanoma.

O'Rourke MG, Schmidt CW, O'Rourke TR, Ellem KA.

Aust N Z J Surg. 1997 Dec;67(12):834-41. Review.

PMID:
9451336
31.

Hyperphosphorylation of the N-terminal domain of Cdc25 regulates activity toward cyclin B1/Cdc2 but not cyclin A/Cdk2.

Gabrielli BG, Clark JM, McCormack AK, Ellem KA.

J Biol Chem. 1997 Nov 7;272(45):28607-14.

32.
33.

Ultraviolet light-induced G2 phase cell cycle checkpoint blocks cdc25-dependent progression into mitosis.

Gabrielli BG, Clark JM, McCormack AK, Ellem KA.

Oncogene. 1997 Aug 14;15(7):749-58.

34.
35.

A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy.

Ellem KA, O'Rourke MG, Johnson GR, Parry G, Misko IS, Schmidt CW, Parsons PG, Burrows SR, Cross S, Fell A, Li CL, Bell JR, Dubois PJ, Moss DJ, Good MF, Kelso A, Cohen LK, Dranoff G, Mulligan RC.

Cancer Immunol Immunother. 1997 Mar;44(1):10-20.

PMID:
9111579
36.

UVC activation of the HeLa cell membrane "TGF alpha ase," a metalloenzyme.

Piva TJ, Krause DR, Ellem KO.

J Cell Biochem. 1997 Mar 1;64(3):353-68.

PMID:
9057093
37.

Accumulation of p16CDKN2A in response to ultraviolet irradiation correlates with late S-G(2)-phase cell cycle delay.

Wang XQ, Gabrielli BG, Milligan A, Dickinson JL, Antalis TM, Ellem KA.

Cancer Res. 1996 Jun 1;56(11):2510-4.

38.

In memoriam Peter F.L. Boreham (1942-1995).

Upcroft J, Ellem K, Upcroft P, McManus D.

Int J Parasitol. 1996 May;26(5):461-9. No abstract available.

PMID:
8818726
39.

Cytoplasmic accumulation of cdc25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells.

Gabrielli BG, De Souza CP, Tonks ID, Clark JM, Hayward NK, Ellem KA.

J Cell Sci. 1996 May;109 ( Pt 5):1081-93.

40.

Peter F.L. Boreham (1942-1995).

Upcroft J, Ellem K, Upcroft P, McManus D.

Acta Trop. 1996 Feb;60(4):221-4. No abstract available.

PMID:
8659321
41.
42.
43.

Induction of cell surface peptidase activity: a global response to cell stress correlated with apoptosis.

Brown SB, Kluck RM, Ellem KA.

J Cell Biochem. 1994 Mar;54(3):320-31.

PMID:
8200912
44.

The human cell cycle gene CDC25B is located at 20p13.

Lane SA, Baker E, Sutherland GR, Tonks I, Hayward N, Ellem K.

Genomics. 1993 Mar;15(3):693-4. No abstract available.

PMID:
8468065
45.
46.

UV induction of transforming growth factor alpha in melanoma cell lines is a posttranslational event.

Chenevix-Trench G, Cullinan M, Ellem KA, Hayward NK.

J Cell Physiol. 1992 Aug;152(2):328-36.

PMID:
1639867
47.
48.

UVC modulation of epidermal growth factor receptor number in HeLa S3 cells.

Ley KD, Ellem KA.

Carcinogenesis. 1992 Feb;13(2):183-7.

PMID:
1740007
49.
50.

Supplemental Content

Support Center